85 related articles for article (PubMed ID: 1770213)
1. Pharmacokinetic profile of the immunomodulating compound adamantylamide dipeptide (AdDP), a muramyl dipeptide derivative in mice.
Walder P; Buchar E; Machková Z; Vrba T; Flegel M; Janků I; Masek K
Immunopharmacol Immunotoxicol; 1991; 13(1-2):101-19. PubMed ID: 1770213
[TBL] [Abstract][Full Text] [Related]
2. Effects of in vivo administration of adamantylamide dipeptide on bone marrow granulocyte-macrophage hemopoietic progenitor cells (GM-CFC) and on ability of serum of the treated mice to stimulate GM-CFC colony formation in vitro: comparison with muramyl dipeptide and glucan.
Vacek A; Hofer M; Masek K
Immunopharmacol Immunotoxicol; 1999 Feb; 21(1):1-14. PubMed ID: 10084327
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
4. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
5. Analgesic activity of two synthetic immunomodulators, muramyl dipeptide and adamantylamide dipeptide in mice and rats.
Horák P; Masek K
Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):569-74. PubMed ID: 2976106
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
8. The immunomodulatory property of a novel synthetic compound adamantylamide dipeptide.
Masek K; Seifert J; Flegel M; Krojidlo M; Kolínsky J
Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):667-9. PubMed ID: 6530904
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
[TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
11. Metabolic disposition of 14C-muroctasin in laboratory animals.
Ono K; Masayasu H; Hashimoto F; Yamada M; Takegoshi T
Arzneimittelforschung; 1988 Jul; 38(7A):1009-14. PubMed ID: 3190792
[TBL] [Abstract][Full Text] [Related]
12. Restoration of femoral GM-CFC progenitors in sublethally irradiated mice of various ages treated with liposomal adamantylamide dipeptide.
Kasná A; Turánek J; Vacek A; Záluská D; Knötigová P; Masek K
Int Immunopharmacol; 2004 Aug; 4(8):1099-106. PubMed ID: 15222985
[TBL] [Abstract][Full Text] [Related]
13. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K
Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522
[TBL] [Abstract][Full Text] [Related]
14. Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice.
Becker PD; Corral RS; Guzmán CA; Grinstein S
Vaccine; 2001 Sep; 19(32):4603-9. PubMed ID: 11535307
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cephalexin in calves after intravenous and subcutaneous administration.
Garg SK; Chaudhary RK; Srivastava AK
Acta Vet Hung; 1996; 44(2):195-201. PubMed ID: 8908743
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of radiolabelled quinlukast in rats.
Syrovatko M; Laznickova A; Laznicek M
J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423--a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity.
Smrdel P; Grabnar I; Locatelli I; Cerne M; Andrensek S; Kovacic N; Kristl A; Bogataj M; Urleb U; Mrhar A
Drug Dev Ind Pharm; 2009 Nov; 35(11):1293-304. PubMed ID: 19832629
[TBL] [Abstract][Full Text] [Related]
18. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic profile of cefotaxime in goats.
Atef M; Ramadan A; Afifi NA; Youssef SA
Res Vet Sci; 1990 Jul; 49(1):34-8. PubMed ID: 2382053
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of nonspecific immunity, haemopoiesis and protection of mice against radiation injury by 1-adamantylamide-L-alanyl-D-isoglutamine incorporated in liposomes.
Turánek J; Záluská D; Vacek A; Borkovcová P; Thurnvaldová J; Bláha L; Masek K
Int Immunopharmacol; 2001 Jan; 1(1):167-75. PubMed ID: 11367514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
